Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort …

…, C Thibeault, S Jentzsch, ET Helbig… - The Lancet …, 2021 - thelancet.com
Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …

[PDF][PDF] A time-resolved proteomic and prognostic map of COVID-19

…, D Ludwig, C Correia-Melo, SK Aulakh, ET Helbig… - Cell systems, 2021 - cell.com
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …

[HTML][HTML] Increased risk of severe clinical course of COVID-19 in carriers of HLA-C* 04: 01

…, V Ilinsky, I Popov, J Balnis, A Jaitovich, ET Helbig… - …, 2021 - thelancet.com
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
there has been increasing urgency to identify pathophysiological characteristics leading to …

[HTML][HTML] Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses

…, S Thada, K Dietert, L Bauer, A Schäfer, ET Helbig… - Nature …, 2018 - nature.com
Live attenuated vaccines are generally highly efficacious and often superior to inactivated
vaccines, yet the underlying mechanisms of this remain largely unclear. Here we identify …

[PDF][PDF] Complement activation induces excessive T cell cytotoxicity in severe COVID-19

…, I Gemünd, M Barone, P Tober-Lau, ET Helbig… - Cell, 2022 - cell.com
Severe COVID-19 is linked to both dysfunctional immune response and unrestrained
immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, …

[HTML][HTML] Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany

…, P Tober-Lau, D Hillus, ET Helbig… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

…, E Binatti, E Scarpini, ET Helbig… - Human molecular …, 2022 - academic.oup.com
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a
deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our …

[HTML][HTML] A proteomic survival predictor for COVID-19 patients in intensive care

…, C Correia-Melo, LJ Lippert, ET Helbig… - PLOS Digital …, 2022 - journals.plos.org
Global healthcare systems are challenged by the COVID-19 pandemic. There is a need to
optimize allocation of treatment and resources in intensive care, as clinically established risk …

[HTML][HTML] Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic …

…, B Mühlemann, ET Helbig, M Mittermaier, T Lingscheid… - Infection, 2021 - Springer
Purpose Adequate patient allocation is pivotal for optimal resource management in strained
healthcare systems, and requires detailed knowledge of clinical and virological disease …

[HTML][HTML] Outbreak of SARS-CoV-2 B. 1.1. 7 lineage after vaccination in long-term care facility, Germany, February–March 2021

…, D Hillus, J Spieckermann, ET Helbig… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
One week after second vaccinations were administered, an outbreak of B. 1.1. 7 lineage
severe acute respiratory syndrome coronavirus 2 infections occurred in a long-term care facility …